European Society of Gynaecological Oncology

Last updated
Formation1983
Type Medical association
Professional association
Location
Membership
> 1,000
Calvin Hu
Website esgo.org

The European Society of Gynaecological Oncology (ESGO) is a Europe-wide society of health care professionals and researchers specializing in the study, prevention, treatment and care of gynaecological cancers. The society, which has more than 2,600 members worldwide, was founded in Venice, Italy, in 1983. [1]

Contents

Activities

Conferences

ESGO's annual conference regularly attracts over 1,500 participants, and enables European health care professionals and researchers involved in the field of gynaecological oncology to network, discuss, debate, and disseminate new medical and scientific studies relating to the treatment and care of gynaecological cancer.

Training and accreditation

In cooperation with the European Board and College of Obstetrics and Gynaecology (EBCOG) and on behalf of the European Union of Medical Specialists (UEMS), ESGO provides certification for trained gynaecologic oncologists and also accredits relevant instructional institutions. ESGO's gynaecological oncology training and accreditation programmes have become recognized standards in a number of European countries. [2] ESGO organizes a number of educational events, workshops and backed meetings throughout the year and provides travel grants to its members. [3]

ESGO is also active in developing educational tools such as videos, DVDs, and webcast lectures for the use of relevant health professionals. [4]

Journal

ESGO's peer-reviewed official medical journal, the International Journal of Gynecological Cancer (IJGC), is annually published nine times and covers research related to gynaecological cancer such as experimental studies, chemotherapy, radiotherapy, diagnostic techniques, pathology epidemiology and surgery. [5]

Prof. Dr. Pedro Ramirez, MD is the current editor-in-chief. [6]

Awards

In 2017, ESGO created the Helga Salvesen Award to recognise researchers who make outstanding contributions to the field. [7]

ESGO Networks

Currently, ESGO has several networks:

See also

Related Research Articles

Obstetrics and gynaecology is the medical specialty that encompasses the two subspecialties of obstetrics and gynecology. The specialization is an important part of care for women's health.

<span class="mw-page-title-main">Cervical cancer</span> Cancer arising from the cervix

Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Early on, typically no symptoms are seen. Later symptoms may include abnormal vaginal bleeding, pelvic pain or pain during sexual intercourse. While bleeding after sex may not be serious, it may also indicate the presence of cervical cancer.

<span class="mw-page-title-main">International Federation of Gynaecology and Obstetrics</span> Professional medical organization

The International Federation of Gynaecology and Obstetrics, usually just FIGO ("fee'go") as the acronym of its French name Fédération Internationale de Gynécologie et d'Obstétrique, is a worldwide non-governmental organisation representing obstetricians and gynaecologists in over one hundred territories. It was founded on 26 July 1954 in Geneva, Switzerland, to "promote the well-being of women and to raise the standard of practice in obstetrics and gynaecology". Membership is currently composed of 132 professional societies of obstetricians and gynaecologists worldwide.

The Society of Gynecologic Oncology (SGO), headquartered in Chicago, Illinois, is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers, affecting the uterus, fallopian tubes, ovaries, cervix, vagina, and vulva. As a 501(c)(6) organization, the SGO contributes to the advancement of women’s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations.

Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers.

A fellowship is the period of medical training, in the United States and Canada, that a physician, dentist, or veterinarian may undertake after completing a specialty training program (residency). During this time, the physician is known as a fellow. Fellows are capable of acting as an attending physician or a consultant physician in the specialist field in which they were trained, such as internal medicine or pediatrics. After completing a fellowship in the relevant sub-specialty, the physician is permitted to practice without direct supervision by other physicians in that sub-specialty, such as cardiology or oncology.

<span class="mw-page-title-main">Oncology</span> Branch of medicine dealing with, or specializing in, cancer

Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:

The Society of Obstetricians and Gynaecologists of Canada (SOGC) is a national medical society in Canada, representing over 4,000 obstetricians/gynaecologists, family physicians, nurses, midwives, and allied health professionals in the field of sexual reproductive health.

Master of Medicine (MMed) is a postgraduate professional clinical degree awarded by medical schools to physicians following a period of instruction, supervised clinical rotations, and examination. The degree usually takes three years to complete, but may take up to four years in some countries. It is awarded by only medical subspecialties and usually includes a dissertation component.before enrollment in this program,medical graduate has to pass the entrance test. The degree may complement an existing fellowship in the chosen specialty or be the sole qualification necessary for registration as a specialist.

The following outline is provided as an overview of and topical guide to obstetrics:

Jonathan S. Berek, MD MMS is the Laurie Kraus Lacob Professor at the Stanford University School of Medicine, Director of the Stanford Women's Cancer Center, and Senior Advisor, Stanford Cancer Institute. He is a recent past Fellow in the Stanford Distinguished Careers Institute.

Texas Oncology is a network of 460+ physicians and oncology specialists who provide advanced treatment options to cancer patients in underserved rural and urban communities throughout Texas, with one office in New Mexico and one in Oklahoma. More than 68,000 patients are treated within the Texas Oncology network annually.

<span class="mw-page-title-main">Julian C. Josey Jr.</span>

Julian C. Josey Jr. is a radiation oncologist at the Gibbs Cancer Center & Research Institute in Spartanburg, South Carolina. A native of Spartanburg, he has been a leader in the diagnosis and treatment of cancer for more than 40 years.

<span class="mw-page-title-main">Binaytara Foundation</span> U.S. nonprofit organization

The Binaytara Foundation (BTF) was established in 2007 by Dr. Binay Shah and wife Tara Shah with the goal of promoting health and education in underprivileged societies. The BTF is a Washington State nonprofit organization exempt from taxation pursuant to Section 501(c)(3) of the Internal Revenue Code. BTF has founded multiple programs in underdeveloped and developing countries to improve access to healthcare. Recent accomplishments include building a 25-bed cancer hospital in Nepal in 2018 and breaking ground on their new 200-bed facility in 2022.

Sven Becker is a German gynaecologist, gynaecologic surgeon, and oncologist.

Helga Birgitte Salvesen was a Norwegian physician and professor of medicine at the University of Bergen.

Bradley J. Monk is an American gynecologic oncologist, academician and researcher. He is a Professor on the Clinical Scholar Track in the Department of Obstetrics and Gynecology at the University of Arizona College of Medicine in Phoenix, Arizona, as well as at the Creighton University School of Medicine in Omaha, Nebraska. He also serves as Director of the Division of Gynecologic Oncology at the St. Joseph's Hospital and Medical Center in Phoenix.

Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine.

<span class="mw-page-title-main">Susana Banerjee</span>

Susana Banerjee is a Consultant Medical Oncologist and Research Lead within the Gynaecology Unit at London's, The Royal Marsden. She holds the title of Professor in Women's Cancers and is a Team Leader at Institute of Cancer Research.

References

  1. "About ESGO: History". European Society of Gynaecological Oncology. Archived from the original on 2012-03-28.
  2. "About ESGO: Training and Accreditation". European Society of Gynaecological Oncology. Archived from the original on 2022-04-07.
  3. "ESGO activities: Grants". European Society of Gynaecological Oncology. Archived from the original on 2012-03-07.
  4. "About ENGOT". European Society of Gynaecological Oncology. Archived from the original on 2012-03-12.
  5. "About ESGO: Journal". European Society of Gynaecological Oncology. Archived from the original on 2012-03-05.
  6. "The International Journal of Gynecological Cancer (IJGC)". Archived from the original on 2022-04-04.
  7. "ESGO Helga Salvesen Award for the Best contribution in Translational research". European Society of Gynaecological Oncology . Retrieved 2023-10-28.
  8. "ESGO". European Society of Gynaecological Oncology. Archived from the original on 2022-04-07.